Influence of 1,25-dihydroxy-vitamin D3 and vitamin D3 analogs on keratinocyte growth and differentiation

Acta Dermato-Venereologica, Supplement

Volumn , Issue 202, 1999, Pages 1-23

  Gniadecki, Robert ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CATENIN; CADHERIN; CALCIPOTRIOL; CALCITRIOL; COLECALCIFEROL DERIVATIVE; CYTOKINE; DNA; GROWTH FACTOR; INTEGRIN; INVOLUCRIN; KERATIN; LEXACALCITOL; LYMPHOKINE; MC 1301; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C; PROTEIN TYROSINE KINASE; RAF PROTEIN; RO 24 2090; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VINCULIN; VITAMIN D RECEPTOR;

CANCER CELL; CELL DIFFERENTIATION; CELL GROWTH; DNA SYNTHESIS; DRUG POTENCY; ENZYME ACTIVATION; EPIDERMIS HYPERPLASIA; GENE; HUMAN; HYPERCALCEMIA; KERATINOCYTE; MITOSIS; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TOPICAL DRUG ADMINISTRATION;

EID: 0033058233     PISSN: 03658341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (128)

1. 3. Proc Natl Acad Sci USA 1981; 78: 4990-4994.
2. Allen E, Yu Q.-C, Fuchs E. Mice expressing a mutant desmosomal cadherin exhibit abnormalities in desmosomes, proliferation, and epidermal differentiation. J Cell Biol 1996; 13: 1367-1382.
3. Amagai M. Adhesion molecules. I: Keratinocyte-keratinocyte interactions; cadherins and pemphigus. J Invest Dermatol 1995; 10: 146-152.
4. Barrandon Y, Green H. Three clonal types of keratinocyte with different capacities for multiplication. Proc Natl Acad Sci USA 1987; 84: 2302-2306.
5. Barsony J, Marx SJ. Rapid accumulation of cyclic GMP near activated vitamin D receptors. Proc Natl Acad Sci USA 1991; 88: 1436-1440.
6. Barsony J, Renyi I, McKoy W. Subcellular distribution of normal and mutant vitamin D Receptors in living cells. Studies with a novel fluorescent ligand. J Biol Chem 1997; 27: 5774-5782.
7. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Flow cytometric identification of proliferative subpopulations within normal human epidermis and the localization of the primary hyperproliferative population in psoriasis. J Exp Med 1993; 17: 1271-1281.
8. Bata-Csorgo Z, Hammerberg C, Voorhees JJ, Cooper KD. Kinetics and regulation of human keratinocyte stem cell growth in short-term primary ex vivo culture. Cooperative growth factors from psoriatic lesional T lymphocytes stimulate proliferation among psoriatic uninvolved, but not normal, stem keratinocytes. J Clin Invest 1995; 95: 317-327.
9. Behrens J, Vakaet L, Friis R, Winterhager E, Roy FV, Mareel MM, Birchmerier W. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/β-catenin complex in cells transformed with a temperature-sensitive v-src gene. J Cell Biol 1993; 12: 757-766.
10. 3. Mol Cell Endocrinol 1993; 90: 231-238.
11. 3 stimulates expression and translocation of protein kinase Cα and Cδ via a nongenomic mechanism and rapidly induces phosphorylation of a 33-kDa protein in acute promyelocytic NB4 cells. J Biol Chem 1996; 27: 16090-16096.
12. 3 is independent of nuclear receptor binding. J Biol Chem 1995; 27: 15962-15965.
13. 3 analogues: a novel class of potent regulators of cell growth and immune responses. Biochem Pharmacol 1991; 42: 1569-1575.
14. 2+-indpendent isoforms of protein kinase C in rat colonocytes. J Clin Invest 1995; 95: 2215-2221.
15. Blenis J. Signal transduction via the MAP kinases: Proceed at your own RSK. Proc Natl Acad Sci USA 1993; 90: 5889-5892.
16. Bollag WB, Xiong Y, Ducote J, Harmon CS. Regulation of foslacZ fusion gene expression in primary mouse epidermal keratinocytes isolated from transgenic mice. Biochem J 1994; 30: 263-270.
17. 3 on primary mouse epidermal keratinocyte proliferation. J Cell Physiol 1995; 16: 248-256.
18. Bonfini L, Migliaccio E, Pelicci G, Lanfrancone L, Pelicci P. Not all She's roads lead to Ras. Trends Biochem Sci 1996; 21: 257-261.
19. Bouillon R, Okamura WH, Norman AW. Structure-function relationships in the vitamin D endocrine system. Endocr. Rev 1995; 16: 200-257.
20. Bower M, Colston KW, Stein RC, Hedley A, Gazet JC, Ford HT, Combes RC. Topical calcipotriol treatment in advanced breast cancer. Lancet 1991; 33: 701-702.
21. Boyce ST, Ham RG. Calcium-regulated differentiation of normal human epidermal keratinocytes in chemically defined clonal cultures and serum-free serial cultures. J Invest Dermatol (Suppl.) 1983; 81: 33-40.
22. 3. Interplay with retinoid and thyroid hormone signalling. Eur J Biochem 1995; 23: 517-527.
23. Carlberg C, Bendik I, Wyss A, Meier E, Sturzenbecker LJ, Grippo JF, Hunziker W. Two nuclear signalling pathways for vitamin D. Nature 1993; 36: 657-660.
24. 3 stimulates differentiation of squamous carcinoma cell line in the raft culture. Anticancer Res 1996; 16: 337-347.
25. 3. Biochem J 1996; 31: 361-371.
26. 3. J Clin Endocrinol Metab 1983; 56: 824-830.
27. Colston KW, Chander SK, Mackay AG, Coombes RC. Effects of synthetic vitamin D analogues on breast cancer cell proliferation in vivo and in vitro. Biochem. Pharmacol 1992; 44: 693-702.
28. Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem 1993; 26: 14553-14556.
29. 3-mediated rapid stimulation of intestinal calcium transport (transcaltachia). Endocrinology 1990; 12: 39-45.
30. 3 analogue MC903: modulations and interrelations. Br J Dermatol 1991; 12: 221-229.
31. Egan SE, Giddings BW, Brooks MW, Buday L, Sizeland AM, Weinberg RA. Association of Sos Ras exchange protein with Grb2 is implicated in tyrosine kinase signal transduction and transformation. Nature 1993; 36: 45-51.
32. 3: an extraordinarily potent inhibitor of leukemic cell growth in vitro. Blood 1994; 84: 1960-1967.
33. 3 analogues: a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines. Cancer Res 1995; 55: 2822-2830.
34. 3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression and induces apoptosis in HL-60 leukemic cells. Cancer Res 1996; 56: 3570-3576.
35. 3 analogs and 9-cis retinoic acid. J Clin Invest 1997; 99: 349-360.
36. Filvaroff E, Stern DF, Dotto GP. Tyrosine phosphorylation is an early and specific event involved in primary keratinocyte differentiation. Mol Cell Biol 1990; 10: 1164-1173.
37. Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Lochner D, Birchmeir W. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J. Cell Biol 1991; 11: 173-185.
38. Fuller LC, Allen MH, Montesu M, Barker JNWN, MacDonald DM. Expression of E-cadherin in human epidermal non-melanoma cutaneous tumours. Br J Dermatol 1996; 13: 28-32.
39. 3: a cell biological study. Br J Dermatol 1993; 12: 666-673.
40. Gilman MZ. The c-fos serum responsive element responds to protein kinase C-dependent and-independent signals but not to cyclic AMP. Genes Dev 1988; 2: 394-402.
41. 3. Ph.D. Thesis University of Copenhagen 1995.
42. Gniadecki R. Regulation of keratinocyte proliferation. Gen. Pharmacol 1998; 30: 619-622.
43. Gniadecki R. Disruption of the vertical calcium gradient in murine epidermis treated with a vitamin D analog KH 1060. Acta Derm Venereol (Stockh) 1998; 78: 164-168.
44. Gottlieb AB. Immunologic mechanisms in psoriasis. J Invest Dermatol (Suppl.) 1990; 95: 18S-19S.
45. Gumbiner BM. Signal transduction of β-catenin. Curr Opin Cell Biol 1995; 7: 634-640.
46. Gumbiner BM. Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 1996; 84: 345-357.
47. Gupta AK, Fisher GJ, Elder JT, Nickoloff BJ, Voorhees JJ. Sphingosine inhibits phorbol-ester-induced inflammation, ornithine decarboxylase activity, and activation of protein kinase C in mouse skin. J Invest Dermatol 1988; 91: 486-491.
48. 3 are mediated exclusively through the genomic signaling pathway. Endocrinology 1996; 13: 1554-1561.
49. Hennings H, Holbrook K. Calcium regulation of cell-cell contact and differentiation of epidermal cells in culture. Exp. Cell Res. 1983; 14: 127-142.
50. Hermiston ML, Gordon JI. In vivo analysis of cadherin function in the mouse intestinal epithelium: essential roles in adhesion, maintenance of differentiation, and regulation of programmed cell death. J Cell Biol 1995; 12: 489-506.
51. Hickish T, Cunningham D, Colston K, Millar BC, Sandle J, Mackay AG, Soukop M, Sloane J. The effect of 1,25-dihydroxyvitamin D3 on lymphoma cell lines and expression of vitamin D receptor in lymphoma. Br J Cancer 1993; 68: 668-672.
52. Hino H, Kobayasi T, Asboe-Hansen G. Desmosome formation in normal human epidermal cell culture. Acta Derm. Venereol 1982; 62: 185-191.
53. Hosomi J, Hosoi J, Abe E, Suda T, Kuroki T. Regulation of terminal differentiation of cultured mouse epidermal cells by 1,25-dihydroxyvitamin D3. Endocrinology 1983; 113: 1950-1957.
54. Itin PH, Pittelkow MR, Kumar R. Effects of vitamin D metabolites on proliferation and differentiation of cultured human epidermal keratinocytes grown in serum-free or defined culture medium. Endocrinology 1994; 13: 1793-1798.
55. Jiang CK, Magnaldo T, Ohtsuki M, Freedberg IM, Bernerd F, Blumenberg M. (1993). Epidermal growth factor and transforming growth factor α specifically induce the activation- and hyperproliferation-associated keratins 6 and 16. Proc Natl Acad Sci USA 1993; 90: 6786-6790.
56. Jones G, Calverley MJ. A dialogue on analogues. Trends Endocrinol Metab 1993; 4: 297-303.
57. Jones PH, Watt FM. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression. Cell 1993; 73: 713-724.
58. Jones PH, Harper S, Watt FM. Stem cell patterning and fate in human epidermis. Cell 1995; 80: 83-93.
59. Kahlen JP, Carlberg C. Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter. Biochem. Biophys Res Commun 1994; 20: 1366-1372.
60. 3 stimulates phopsholipase C-γ in rat colonocytes: role of c-Src in PLC-γ activation. J Clin Invest 1997; 99: 1831-1841.
61. Klymkowsky MW, Parr B. The body language of cells: the intimate connection between cell adhesion and behavior. Cell 1995; 83: 5-8.
62. Kragballe K. Treatment of psoriasis with calcipotriol and other vitamin D analogues. J Am Acad Dermatol 1992; 27: 1001-1008.
63. 3 analogue stimulates terminal differentiation and inhibits proliferation of cultured human keratinocytes. Arch Dermatol Res 1990; 28: 164-167.
64. Kragballe K, Gjertsen BT, De Hoop D, Karlsmark T, van de Kerkhof PC, Larko O, Nieboer C, Roed Petersen J, Strand A, Tikjøb G. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1991; 33: 193-196.
65. 3 analogue KH 1060 in the topical therapy of psoriasis: Results of a dose-ranging study. Acta Derm Venereol 1994; 74: 398-402.
66. Kragballe K, Steijlen PM, Ibsen HH, van de Kerkhof PC, Esmann J, Sørensen LH, Axelsen MB. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol 1995; 13: 556-560.
67. Krane JF, Gottlieb AB, Carter DM, Krueger JG. The insulin-like growth factor I receptor is overexpressed in psoriatic epidermis, but is differentially regulated from the epidermal growth factor receptor. J Exp Med 1992; 17: 1081-1090.
68. Larue L, Ohsugi M, Hirchenhaim J, Kemler R. E-cadherin null mutant embryos fail to form a trophoderm epithelium. Proc Natl Acad Sci USA 1994; 91: 8263-8267.
69. Lewis JE, Jensen PJ, Johnson KR, Wheelock MJ. E-cadherin mediates adherens junction organization through protein kinase C. J Cell Sci 1994; 10: 3615-3621.
70. Lewis JE, Jensen PJ, Wheelock MJ. Cadherin function is required for human keratinocytes to assemble desmosomes and stratify in response to calcium. J Invest Dermatol 1994; 10: 870-877.
71. 3 activates Raf kinase and Raf perinuclear translocation via a protein kinase C-dependent pathway. J Biol Chem 1993; 26: 25132-25138.
72. 3 leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 1996; 10: 142-153.
73. 3 analogues and their 20-epi homologues with the vitamin D receptor. J Biol Chem 1997; 27: 3336-3345.
74. Lucker GP, Steijen PM, Suykerbuyk EJ, Kragballe K, Brandrup F, van de Kerkhof PC. Flow-cytometric investigation of epidermal cell characteristics in monogenic disorders of keratinization and their modulation by topical calcipotriol treatment. Acta Derm Venereol 1996; 76: 97-101.
75. 3 and the vitamin D analogue KH1060 induce hyperproliferation in normal mouse epidermis. A BrdUrd/DNA flow cytometric study. Exp Dermatol 1993; 2: 113-120.
76. 3 in the growth and differentiation of human keratinocytes. Biochim Biophys Acta 1991; 1092: 311-318.
77. Mbalaviele G, Dunstan CR, Sasaki A, Williams PJ, Mundy GR, Yoneda T. E-Cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. Cancer Res 1996; 56: 4063-4070.
78. 3 receptors in normal and psoriatic skin. J Invest Dermatol 1991; 97: 230-239.
79. 3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991; 87: 1889-1895.
80. 3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells. Clin Exp Metastasis 1996; 14: 239-245.
81. 3. Biochem J 1993; 28: 675-679.
82. 3 for psoriasis: report of five cases. Calcif Tissue Int. 1986a; 38: 119-122.
83. 3-open-design study. Calcif. Tissue Int 1986b; 39: 209-212.
84. Munker R, Kobayashi T, Elstner E, Norman AW, Uskokovic M, Zhang W, Andreeff M, Koeffler HP. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia. Blood 1996; 88: 2201-2209.
85. Murdoch D, Clissold SP. Calcipotriol. A review of its pharmacological properties and therapeutic use in psoriasis vulgaris. Drugs 1992; 43: 415-429.
86. 3 in human breast-cancer MCF-7 cells is related to promoter selectivity. Int J Cancer 1996; 67: 739-742.
87. 3 analogues is not mediated by inhibition of the AP-1 pathway, but may be related to promoter selectivity. Oncogene 1995; 11: 1853-1858.
88. 3 on calcium transport in perfused chick duodenum: effects of inhibitors. J Bone Miner Res 1987; 2: 99-107.
89. Nemere I, Zhou L.-X, Norman A. Nontranscriptional effects of steroid hormones. Receptor 1993; 3: 277-291.
90. 3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia. J Biol Chem 1994; 26: 23750-23756.
91. 3: a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. J Steroid Biochem Molec Biol 1992; 41: 231-240.
92. 3. J Biol Chem 1993; 26: 20022-20030.
93. Nusse R. A versatile transcriptional effector of wingless signaling. Cell 1997; 89: 321-323.
94. Palmieri Sevier A, Palmieri GM, Baumgartner CJ, Britt LG. Case report: long-term remission of parathyroid cancer: possible relation to vitamin D and calcitriol therapy. Am J Med Sci 1993; 30: 309-312.
95. Parkinson EK, Emmerson A. The effects of tumour promoters on the multiplication and morphology of cultured human epidermal keratinocytes. Carcinogenesis 1982; 3: 525-531.
96. Rebel VI, Ossenkoppele GJ, van de Loosdrecht AA, Wijermans PW, Beelen RH, Langenhuijsen MM. Monocytic differentiation induction of HL-60 cells by MC 903, a novel vitamin D analogue. Leuk Res 1992; 16: 443-451.
97. Rimm DL, Koslov ER, Kebriaei P, Cianci CD, Morrow JS. α1(E)-Catenin is an actin-binding and-bundling protein mediating the attachment of F-actin to the membrane adhesion complex. Proc Natl Acad Sci USA 1995; 92: 8813-8817.
98. Rochat A, Kobayashi K, Barrandon Y. Location of stem cells of human hair follicles by clonal analysis. Cell 1994; 76: 1063-1073.
99. Schrader M, Muller KM, Carlberg C. Specificity and flexibility of vitamin D signaling. Modulation of the activation of natural vitamin D response elements by thyroid hormone. J Biol Chem 1994; 26: 5501-5504.
100. 3-thyroid hormone receptor heterodimer polarity directs ligand sensitivity of transactivation. Nature 1994; 37: 382-386.
101. Sherr CJ. Mammalian G1 cyclins. Cell 1993; 73: 1059-1065.
102. Shiozaki H, Tahara H, Oka H, Miyata M, Kobayashi T, Tamura S, Iihara K, Doki Y, Hirano S, Takeichi M, Mori T. Expression of immunoreactive E-cadherin adhesion molecules in human cancer. Am J Pathol 1991; 13: 17-23.
103. 3. Endocrinology 1995; 13: 20-26.
104. 3. J Biol Chem 1995; 27: 6639-6643.
105. 3 on the morphologic and biochemical differentiation of cultured human keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-714.
106. 3 can be a safe and effective therapy for psoriasis. J Am Acad Sci 1988; 19: 5160-528.
107. 3 on proliferation and differentiation of a human megakaryoblastic leukemia cell line. Biochem Pharmacol 1992; 43: 2292-2295.
108. Studzinski GP, McLane JA, Uskokovic MR. Signaling pathways for vitamin D-induced differentiation: implications for therapy of proliferative and neoplastic diseases. Crit Rev Eukaryot Gene Expr 1993; 3: 279-312.
109. 3 in intestinal tract, stomach, kidney, skin, pituitary, and parathyroid. Science 1979; 20: 1188-1190.
110. Stumpo DJ, Stewart TN, Gilman MZ, Blackshear PJ. Identification of c-fos sequence involved in induction by insulin and phorbol esters. J Biol Chem 1988; 26: 1611-1614.
111. 3 analogues in a cell density-, calcium- and serum-dependent manner. Pharmacol. Toxicol. 1997; 80: 49-56.
112. Takayama T, Shiozaki H, Shibamoto S, Oka H, Kimura Y, Tamura S, Inoue M, Monden T, Ito F, Monden M. β-Catenin expression in human cancers. Am J Pathol 1996; 14: 39-46.
113. Tseng H, Green H. Association of basonuclin with ability of keratinocytes to multiply and with absence of terminal differentiation. J Cell Biol 1994; 12: 495-506.
114. van de Kerkhof PCM. Biological activity of vitamin D analogues in the skin, with special reference to antipsoriatic mechanisms. Br J Dermatol 1995; 13: 675-682.
115. van de Kerkhof PC, Steijlen PM. Topical treatment of pityriasis rubra pilaris with calcipotriol. Br J Dermatol 1994; 13: 675-678.
116. 3 analog KH1060. Proc Natl Acad Sci USA 1996; 93: 10685-10690.
117. 3 in bone. J Biol Chem 1992; 26: 12562-12569.
118. Vleminckx K, Vakaet L, Jr Mareel M, Fiers W, Van Roy F. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991; 66: 107-119.
119. Waga S, Hannon GJ, Beach D, Stillman B. Differential effects by the p25 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature 1994; 36: 574-578.
120. 3 stimulates membrane phosphoinositide turnover, activates protein kinase C and increases cytosolic calcium in rat colonie epithelium. J Clin Invest 1990; 85: 1296-1303.
121. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13: 719-764.
122. 3-treated HL-60 cells. Cancer Res 1997; 57: 2851-2855.
123. Wheelock MJ, Jensen PJ. Regulation of keratinocyte intercellular junction organization and epidermal morphogenesis by E-cadherin. J Cell Biol 1992; 11: 415-425.
124. Wille JJ, Pittelkow MR, Shipley GD, Scott RE. Integrated control of growth and differentiation of normal human prokeratinocytes cultured in serum-free medium: clonal analyses, growth kinetics, and cell-cycle studies. J Cell Physiol 1984; 12: 31-44.
125. 3: role of protein kinase C translocation. Biochem Biophys Res Commun 1989; 16: 1517-1522.
126. Yuspa SH, Ben TB, Hennings H, Lichti U. Divergent responses in epidermal basal cells exposed to the tumor promoter 12-O-tetradeconoyl phorbol-13-acetate. Cancer Res 1982; 42: 2344-2349.
127. Yuspa SH, Ben TB, Hennings H. The induction of epidermal transglutaminase and terminal differentiation by tumour promoters in cultured human epidermal cells. Carcinogenesis 1983; 4: 1413-1418.
128. Zhao Y, Sudol M, Hanafusa H, Krueger JG. Increased tyrosine kinase activity of c-Src during calcium-induced keratinocyte differentiation. Proc Natl Acad Sci USA 1992; 89: 8298-8302.